|
Press Releases |
|
 |
|
Monday, January 17, 2022 |
|
Senior Management Increases Shareholdings in EC Healthcare With Strong Confidence in the Group's Future Development |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that on 14 January 2022, the Group's Chairman, Executive Director and Chief Executive Officer Mr. Tang Chi Fai ("Mr. Tang") more info >> |
|
Monday, January 10, 2022 |
|
医思健康料2022财年第三季度销售额创新高 同比升逾四成 |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然宣布,集团预计2021年10月至12月期间(「季内」)的销售额创新高,同比上升不少于41%。 more info >> |
|
醫思健康料2022財年第三季度銷售額創新高 同比升逾四成 |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)欣然宣佈,集團預計2021年10月至12月期間(「季內」)的銷售額創新高,同比上升不少於41%。 more info >> |
|
EC Healthcare expects to achieve a record-high sales volume in third quarter of FY22, Represents more than 40% Y-o-Y increase |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group expects to achieve a record-high sales volume in the period of October to December 2021 ("the Quarter") , representing a y-o-y increase of no less than 41%. more info >> |
|
Tuesday, November 30, 2021 |
|
医思健康收购香港连锁牙科服务公司 |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然宣布,收购庇利积臣牙科医务有限公司(「目标公司」)55%已发行股本,总代价为约1.29亿港元,其中约1.19亿港元以将以现金支付,余下约一千万港元将透过配发及发行代价股份以每股HK$ 12.557入账列作缴足代价股份偿付。 more info >> |
|
醫思健康收購香港連鎖牙科服務公司 |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)欣然宣佈,收購庇利積臣牙科醫務有限公司(「目標公司」)55%已發行股本,總代價為約1.29億港元,其中約1.19億港元以將以現金支付,餘下約一千萬港元將透過配發及發行代價股份以每股HK$ 12.557入賬列作繳足代價股份償付。 more info >> |
|
EC Healthcare Acquires Hong Kong Dental Services Chain |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group enters into an agreement to acquire 55% of the issued share capital of Bayley & Jackson Dental Surgeons Limited (the "Target Company") more info >> |
|
医思健康公布2021/22年度中期业绩 |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)公布截至2021年9月30日止六个月(「期内」)未经审核之中期业绩。 more info >> |
|
醫思健康公佈2021/22年度中期業績 |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)公佈截至2021年9月30日止六個月(「期內」)未經審核之中期業績。 more info >> |
|
EC Healthcare Announces FY2021/22 Interim Results |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its unaudited interim results for the six months ended 30 September 2021 (the "Period"). more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
飛魚科技公佈2024年年度全年業績公告
Mar 28, 2025 23:48 HKT/SGT
|
|
|
2025孤獨星球-星光跑:用愛點亮"星星的孩子"未來
Mar 28, 2025 22:52 HKT/SGT
|
|
|
聯想控股2024年扭虧為盈 效能釋放能否助推回歸增長曲線
Mar 28, 2025 22:40 HKT/SGT
|
|
|
2025孤独星球 - 星光跑:用爱点亮"星星的孩子"未来
Mar 28, 2025 22:35 HKT/SGT
|
|
|
联想控股2024年扭亏为盈 效能释放能否助推回归增长曲线
Mar 28, 2025 22:32 HKT/SGT
|
|
|
Hua Medicine Announces 2024 Annual Results
Mar 28, 2025 21:51 HKT/SGT
|
|
|
華領醫藥公佈2024年全年業績
Mar 28, 2025 21:38 HKT/SGT
|
|
|
华领医药公布2024年全年业绩
Mar 28, 2025 21:28 HKT/SGT
|
|
|
Analogue FY2024 Revenue Rose to HK$6,450 Million with Adjusted Profit Attributable to Owners of the Company Increased to HK$206 Million
Mar 28, 2025 21:21 HKT/SGT
|
|
|
安樂工程2024年收益升至64.50億港元 經調整本公司擁有人應佔溢利增至2.06億港元
Mar 28, 2025 21:06 HKT/SGT
|
|
|
Nissin Foods Announces 2024 Annual Results
Mar 28, 2025 20:56 HKT/SGT
|
|
|
安乐工程2024年收益升至64.50亿港元 经调整本公司拥有人应占溢利增至2.06亿港元
Mar 28, 2025 20:43 HKT/SGT
|
|
|
Kristof Schöffling及Move Digital領導2025年全球科技革新,推動 AI、區塊鏈及機器人技術突破
Mar 28, 2025 20:27 HKT/SGT
|
|
|
Kristof Schöffling和Move Digital引领2025年全球科技变革,推动 AI、区块链和机器人技术突破
Mar 28, 2025 19:55 HKT/SGT
|
|
|
光大环境(00257)派息稳定增长 行业龙头地位牢固
Mar 28, 2025 19:22 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|